Market Overview

8 Biggest Price Target Changes For Monday

Related TROV
The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch
The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs
Related NVDA
Citi Adds Nvidia, Marvell Technology To Holiday Shopping List
Nvidia Bounces Back After News Of Potential SoftBank Sale
Podcast: Qualcomm Tech Summit, Intel Analyst Event, Nvidia Robotics (Seeking Alpha)


  • Credit Suisse lowered the price target on Bristol-Myers Squibb Co (NYSE: BMY) from $86 to $63. Bristol-Myers Squibb shares closed at $63.28 on Friday.
  • Jefferies boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $56 to $69. NVIDIA shares closed at $58.20 on Friday.
  • Goldman Sachs boosted the price target for BlackRock, Inc. (NYSE: BLK) from $390 to $400. BlackRock shares closed at $374.75 on Friday.
  • Cantor Fitzgerald raised the price target on TrovaGene Inc (NASDAQ: TROV) from $5 to $7. TrovaGene shares closed at $5.20 on Friday.
  • Citi increased Raptor Pharmaceutical Corp. (NASDAQ: RPTP) price target from $6 to $8. Raptor Pharmaceutical shares closed at $6.89 on Friday.
  • CLSA increased Reynolds American, Inc. (NYSE: RAI) price target from $52 to $54. Reynolds American shares closed at $48.92 on Friday.
  • UBS raised Ferrari N.V. (NYSE: RACE) price target from $50 to $53. Ferrari shares closed at $46.88 on Friday.
  • Credit Suisse raised the price target for Merck & Co., Inc. (NYSE: MRK) from $62 to $73. Merck shares closed at $63.86 on Friday.

Latest Ratings for TROV

Jun 2018Maxim GroupUpgradesHoldBuy
Nov 2017Maxim GroupDowngradesBuyHold
Mar 2017PiperJaffrayDowngradesNeutralUnderweight

View More Analyst Ratings for TROV
View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings


Related Articles (BLK + BMY)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

U.S. Dollar Index Trading Higher, Labor Conditions Improve

Suntrust Highlights The Top 10 Reasons Behind New Instagram 'Stories'